<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the setting of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, the ectopic disposition of <z:chebi fb="23" ids="18059">lipids</z:chebi> may be a cause of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical studies have clearly shown a correlation between the accumulation of <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and heart dysfunction </plain></SENT>
<SENT sid="2" pm="."><plain>In this process, it is likely that there are also changes in the contents of <z:chebi fb="0" ids="26739">sphingolipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="26739">Sphingolipids</z:chebi> are important structural and signaling molecules </plain></SENT>
<SENT sid="4" pm="."><plain>One specific <z:chebi fb="0" ids="26739">sphingolipid</z:chebi>, <z:chebi fb="7" ids="17761">ceramide</z:chebi>, may cause cardiac dysfunction, whereas another, <z:chebi fb="0" ids="37550">sphingosine 1-phosphate</z:chebi>, is cardioprotective </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, the authors focus on the role of <z:chebi fb="0" ids="26739">sphingolipids</z:chebi> in the development and prevention of <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> </plain></SENT>
</text></document>